Swiss National Bank Crinetics Pharmaceuticals, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Swiss National Bank holds 130,900 shares of CRNX stock, worth $7.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

130,900

Previous 130,300 0.46%

Holding current value

$7.16 Million

Previous $5.84 Million 14.56%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$43.83 - $54.98 $26,298 - $32,988	600 Added 0.46%	130,900 $6.69 Million
Q2 2024 Aug 08, 2024	BUY	$42.12 - $51.91 $160,056 - $197,258	3,800 Added 3.0%	130,300 $5.84 Million
Q1 2024 May 07, 2024	BUY	$34.76 - $46.81 $775,148 - $1.04 Million	22,300 Added 21.4%	126,500 $5.92 Million
Q4 2023 Feb 06, 2024	SELL	$25.62 - $37.07 $312,564 - $452,254	-12,200 Reduced 10.48%	104,200 $3.71 Million
Q3 2023 Nov 08, 2023	BUY	$15.97 - $30.59 $546,174 - $1.05 Million	34,200 Added 41.61%	116,400 $3.46 Million
Q2 2023 Aug 09, 2023	BUY	$15.73 - $23.6 $14,157 - $21,240	900 Added 1.11%	82,200 $1.48 Million
Q1 2023 May 10, 2023	SELL	$15.31 - $21.1 $145,445 - $200,450	-9,500 Reduced 10.46%	81,300 $1.31 Million
Q4 2022 Feb 08, 2023	BUY	$15.49 - $19.05 $43,372 - $53,340	2,800 Added 3.18%	90,800 $1.66 Million
Q2 2022 Aug 09, 2022	BUY	$16.49 - $27.64 $153,357 - $257,052	9,300 Added 11.82%	88,000 $1.64 Million
Q1 2022 May 09, 2022	BUY	$17.15 - $28.31 $132,055 - $217,987	7,700 Added 10.85%	78,700 $1.73 Million
Q4 2021 Feb 08, 2022	BUY	$19.35 - $28.41 $414,090 - $607,974	21,400 Added 43.15%	71,000 $2.02 Million
Q2 2021 Aug 06, 2021	BUY	$15.9 - $21.15 $190,800 - $253,799	12,000 Added 31.91%	49,600 $935,000
Q1 2021 May 07, 2021	BUY	$13.3 - $17.55 $18,620 - $24,570	1,400 Added 3.87%	37,600 $575,000
Q2 2020 Aug 05, 2020	BUY	$13.04 - $23.23 $226,895 - $404,202	17,400 Added 92.55%	36,200 $634,000
Q1 2020 May 08, 2020	BUY	$11.52 - $26.46 $10,368 - $23,814	900 Added 5.03%	18,800 $276,000
Q2 2019 Aug 02, 2019	BUY	$21.48 - $27.71 $384,492 - $496,009	17,900 New	17,900 $448,000

Others Institutions Holding CRNX

# of Institutions

240

Shares Held

79.5M

Call Options Held

23.3K

Put Options Held

44.3K

View Full List

About Crinetics Pharmaceuticals, Inc.

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.94B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

More about CRNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Crinetics Pharmaceuticals, Inc. Transaction History